Zhao, H. 2024. Recombinant VSV as a platform for rabies vaccine development: Enhancing immunogenicity and safety. Transactions on Materials, Biotechnology and Life Sciences. 7, (Dec. 2024), 61–67. DOI:https://doi.org/10.62051/g3v8bs44.